Natriuretic peptides, including BNP and NT-proBNP, have emerged as valuable biomarkers in the diagnosis, management, and risk stratification of various cardiac conditions, particularly heart failure. Natriuretic peptides are released from the myocardium, mainly from the ventricles, in response to elevated wall stress and pressure overload. Here, NPPB is linked to heart failure.